Peer Review reports
From: miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
| Original Submission | ||
|---|---|---|
| 19 Jul 2019 | Submitted | Original manuscript |
| 22 Aug 2019 | Reviewed | Reviewer Report - XIAOMIN YING |
| 30 Aug 2019 | Reviewed | Reviewer Report - Hualong Yan |
| 4 Sep 2019 | Reviewed | Reviewer Report - Bushra Ateeq |
| 5 Nov 2019 | Author responded | Author comments - Peng Ge |
| Resubmission - Version 2 | ||
| 5 Nov 2019 | Submitted | Manuscript version 2 |
| 13 Nov 2019 | Reviewed | Reviewer Report - Hualong Yan |
| 22 Nov 2019 | Author responded | Author comments - Peng Ge |
| 22 Nov 2019 | Reviewed | Reviewer Report - XIAOMIN YING |
| Resubmission - Version 3 | ||
| 22 Nov 2019 | Submitted | Manuscript version 3 |
| 28 Nov 2019 | Author responded | Author comments - Peng Ge |
| Resubmission - Version 4 | ||
| 28 Nov 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 29 Nov 2019 | Editorially accepted | |
| 10 Dec 2019 | Article published | 10.1186/s12885-019-6416-4 |
You can find further information about peer review here.